H. Fang, J. Kang, and D. Zhang, Microbial production of vitamin B12: a review and future perspectives. Microbial Cell Factories, vol.16, p.15, 2017.

T. C. Wallace, F. Guarner, K. Madsen, M. D. Cabana, G. Gibson et al., Human gut microbiota and its relationship to health and disease, Nutr Rev, vol.69, issue.7, pp.392-403, 2011.

R. B. Moyes, J. Reynolds, and D. P. Breakwell, Differential staining of bacteria: gram stain, Curr Protoc Microbiol, 2009.

K. I. Mohr, History of Antibiotics Research, Curr Top Microbiol Immunol, vol.398, pp.237-72, 2016.

J. Recktenwald, R. Shawky, O. Puk, F. Pfennig, U. Keller et al., Nonribosomal biosynthesis of vancomycin-type antibiotics: a heptapeptide backbone and eight peptide synthetase modules. Microbiology (Reading, Engl), vol.148, pp.1105-1123, 2002.

P. E. Reynolds, Structure, biochemistry and mechanism of action of glycopeptide antibiotics, Eur J Clin Microbiol Infect Dis, vol.8, issue.11, pp.943-50, 1989.

. Vidal--vancomycine, , 2019.

D. P. Levine, Vancomycin: a history, Clin Infect Dis, vol.42, issue.1, pp.5-12, 2006.

, Notice patient -VANCOMYCINE MYLAN 500 mg, poudre pour solution à diluer pour perfusion ou pour solution buvable -Base de données publique des médicaments, 2019.

G. S. Tillotson, Quinolones: structure-activity relationships and future predictions, Journal of Medical Microbiology, vol.44, issue.5, pp.320-324, 1996.

Å. Popioå?ek and M. Gawroå"ska-grzywacz, The Impact of Modifying the Chemical Structure of Nalidixic Acid on the Antimicrobial Activity of Its Derivatives: A Review, International Research Journal of Pure & Applied Chemistry, vol.7, issue.4, pp.191-202, 2015.

R. Gleckman, S. Alvarez, D. W. Joubert, and S. J. Matthews, Drug therapy reviews: Nalidixic acid, Am J Hosp Pharm, vol.36, issue.8, pp.1071-1077, 1979.

A. E. Clatworthy, E. Pierson, and D. T. Hung, Targeting virulence: a new paradigm for antimicrobial therapy, Nature Chemical Biology, vol.3, issue.9, pp.541-549, 2007.

J. M. Munita and C. A. Arias, Mechanisms of Antibiotic Resistance, Microbiol Spectr, vol.4, issue.2, 2016.

H. Nikaido, RND transporters in the living world, Research in Microbiology, vol.169, issue.7, pp.363-71, 2018.

W. A. Mcguinness, N. Malachowa, and F. R. Deleo, Vancomycin Resistance in Staphylococcus aureus, Yale J Biol Med, vol.90, issue.2, pp.269-81, 2017.

S. Correia, P. Poeta, M. Hébraud, J. L. Capelo, and G. Igrejas, Mechanisms of quinolone action and resistance: where do we stand, J Med Microbiol, vol.66, issue.5, pp.551-560, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01607127

P. Ruggerone, S. Murakami, K. Vargiu, and A. V. Rnd, Efflux Pumps: Structural Information Translated into Function and Inhibition Mechanisms [Internet]. Current Topics in Medicinal Chemistry, 2013.

E. Udho, K. S. Jakes, S. K. Buchanan, K. J. James, X. Jiang et al., Reconstitution of bacterial outer membrane TonB-dependent transporters in planar lipid bilayer membranes, vol.106, pp.21990-21995, 2009.

G. M. Moore and Z. Gitai, Both clinical and environmental Caulobacter species act as opportunistic pathogens. bioRxiv, vol.645515, 2019.

H. Balhesteros, Y. Shipelskiy, N. J. Long, A. Majumdar, B. B. Katz et al., TonBDependent Heme/Hemoglobin Utilization by Caulobacter crescentus HutA, J Bacteriol, vol.15, issue.6, 2017.

K. Subramanian and J. J. Tyson, Spatiotemporal Models of the Asymmetric Division Cycle of Caulobacter crescentus, Results and Problems in Cell Differentiation, pp.23-48, 2017.

C. L. Kirkpatrick and P. H. Viollier, Synthetic Interaction between the TipN Polarity Factor and an AcrAB-Family Efflux Pump Implicates Cell Polarity in Bacterial Drug Resistance, Chemistry & Biology, vol.21, issue.5, pp.657-65, 2014.

. Penicillin's-finder, . Assays, and . Future, Sir Alexander Fleming Says Improved Dosage Method Is Needed to Extend Use Other Scientists Praised Self-Medication Decried. The New York Times, 1945.

, OMS | Premier rapport de l'OMS sur la résistance aux antibiotiques: une menace grave d'ampleur mondiale, 2019.

H. Lam, W. B. Schofield, and C. Jacobs-wagner, A landmark protein essential for establishing and perpetuating the polarity of a bacterial cell, Cell, vol.124, issue.5, pp.1011-1034, 2006.

E. Huitema, S. Pritchard, D. Matteson, S. K. Radhakrishnan, and P. H. Viollier, Bacterial birth scar proteins mark future flagellum assembly site, Cell, vol.124, issue.5, pp.1025-1062, 2006.

C. Watanakunakorn, Mode of action and in-vitro activity of vancomycin, J Antimicrob Chemother, vol.14, pp.7-18, 1984.

A. Zhou, T. M. Kang, J. Yuan, C. Beppler, C. Nguyen et al., Synergistic interactions of vancomycin with different antibiotics against Escherichia coli: trimethoprim and nitrofurantoin display strong synergies with vancomycin against wild-type E. coli, Antimicrob Agents Chemother, vol.59, issue.1, pp.276-81, 2015.

X. Li, P. Plésiat, and H. Nikaido, The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria, Clin Microbiol Rev, vol.28, issue.2, pp.337-418, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01695304

, The caulobacter Tol-Pal complex is essential for outer membrane integrity and the positioning of a polar localization factor

N. T. Liberati, J. M. Urbach, S. Miyata, D. G. Lee, E. Drenkard et al., An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants, Proc Natl Acad Sci, vol.103, issue.8, pp.2833-2841, 2006.

M. Evinger and N. Agabian, Envelope-associated nucleoid from Caulobacter crescentus stalked and swarmer cells, J Bacteriol, vol.132, issue.1, pp.294-301, 1977.

J. H. Miller, Assay of b-galactosidase. In Experiments in Molecular Genetics, pp.352-355, 1972.